BioSpace News Archive

SentreHEART, Inc. announced its participation and scheduled presentations at the Heart Rhythm Society’s 40th Annual Heart Rhythm Scientific Sessions, in San Francisco, CA on May 8-11, 2019.

SpringWorks Therapeutics, Inc. announced that the first patient has been dosed in a Phase 1b study to evaluate the combination of SpringWorks Therapeutics’ investigational MEK inhibitor, PD-0325901, and BeiGene, Ltd.’s investigational RAF dimer inhibitor, lifirafenib, in patients with advanced or refractory solid tumors.

Observational registry (at midway point) with retrospective data collection provides preliminary evaluation of premature versus term and near-term neonates with pulmonary hypertension receiving inhaled nitric oxide

First and only medicines approved for patients with either wild-type or hereditary transthyretin amyloid cardiomyopathy

Canadian Mental Health Association calls for new mental health promotion strategy to get out in front of mental illness.

Leading personalized medicine consulting firm Clarkston Consulting announced the launch of Cell Therapy Orchestration Platform, a proprietary, all-in-one platform for managing the complex requirements to produce and distribute gene and cell therapy treatments.

Sierra Oncology, Inc. announced that members of its senior management team will be attending the SunTrust Robinson Humphrey 5th Annual Life Sciences Conference in New York on May 8th, and the Oppenheimer Oncology Insight Summit in New York on May 16th.

Data demonstrating that AI accurately predicts Respiratory Distress Syndrome (RDS) in premature babies, enables company to accelerate product development and begin next phase clinical studies in Europe, the US and China

New Stent System Now Available for Treating Patients with Deep Venous Blockages

Big Rapids residents with tattoo regret can now receive superior laser tattoo removal treatment at No Regerts, Michigan’s newest up-and-coming laser clinic.